Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387135536> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4387135536 abstract "<h3>Introduction/Background</h3> The incidence of brain metastases (BMs) in ovarian cancer (OC) is ranging from 0.49% to 6.1%. This heterogeneity can be partially explained by diagnostic procedures and treatment improvement, influencing positively on detection and outcome rates. We aimed to analyze patients with BMs from OC in a single center experience and calculate interval between diagnosis of OC and BMs, interval between BMs and data of last contact. <h3>Methodology</h3> All women with OC with BMs, who were treated in Oncogynecological Department of N.N. Alexandrov National Cancer Centre of Belarus between January 1980 and December 2022 were retrospectively identified. The main criteria were serous carcinoma, endometrioid carcinoma and clear cell carcinoma and brain metastases. All data and follow-up were taken from medical records and analyzed afterward. Interval between diagnosis of OC and BMs, interval between BMs and data of last contact were studied with the use of Kaplan-Meier curves. The statistical analyses were performed using SPSS statistical software (version 23.0). A two-sided p-value < 0.05 was considered statistically significant. <h3>Results</h3> 106 patients with BMs met the inclusion criteria. We divided patients into 4 group: 1 -without any treatment, 2- or surgery or chemotherapy or radiology, 3- combining two methods of treatment (chemotherapy with radiology (CR), chemotherapy with surgery (CS), surgery with radiology (SR)), 4 - surgery combined with radiotherapy and chemotherapy. Median time from development of BMs to last contact date for 1st group was 0 month, for 2nd – 3 months (95% CI [1.93; 10.47]), for 3rd – 11,5 months (95% CI [11.29; 20.27]), for 4th – 28 months (95% CI [21.32; 44.68]). When comparing all medians in pairs, statistically significant differences were noted in each comparison (p< 0.05). <h3>Conclusion</h3> The best option for patients with OC with BMs were the application of the multimodal treatment. <h3>Disclosures</h3> The authors have nothing to disclose." @default.
- W4387135536 created "2023-09-29" @default.
- W4387135536 creator A5030380295 @default.
- W4387135536 creator A5055423911 @default.
- W4387135536 creator A5073487280 @default.
- W4387135536 creator A5076828546 @default.
- W4387135536 creator A5090115470 @default.
- W4387135536 creator A5092960838 @default.
- W4387135536 creator A5092960839 @default.
- W4387135536 date "2023-09-01" @default.
- W4387135536 modified "2023-10-18" @default.
- W4387135536 title "#580 Treatment options for patients with brain metastases from ovarian cancer: retrospective monocentric study" @default.
- W4387135536 doi "https://doi.org/10.1136/ijgc-2023-esgo.604" @default.
- W4387135536 hasPublicationYear "2023" @default.
- W4387135536 type Work @default.
- W4387135536 citedByCount "0" @default.
- W4387135536 crossrefType "proceedings-article" @default.
- W4387135536 hasAuthorship W4387135536A5030380295 @default.
- W4387135536 hasAuthorship W4387135536A5055423911 @default.
- W4387135536 hasAuthorship W4387135536A5073487280 @default.
- W4387135536 hasAuthorship W4387135536A5076828546 @default.
- W4387135536 hasAuthorship W4387135536A5090115470 @default.
- W4387135536 hasAuthorship W4387135536A5092960838 @default.
- W4387135536 hasAuthorship W4387135536A5092960839 @default.
- W4387135536 hasBestOaLocation W43871355361 @default.
- W4387135536 hasConcept C120665830 @default.
- W4387135536 hasConcept C121332964 @default.
- W4387135536 hasConcept C121608353 @default.
- W4387135536 hasConcept C126322002 @default.
- W4387135536 hasConcept C126838900 @default.
- W4387135536 hasConcept C143998085 @default.
- W4387135536 hasConcept C150173356 @default.
- W4387135536 hasConcept C167135981 @default.
- W4387135536 hasConcept C2776694085 @default.
- W4387135536 hasConcept C2780427987 @default.
- W4387135536 hasConcept C3019054536 @default.
- W4387135536 hasConcept C44249647 @default.
- W4387135536 hasConcept C509974204 @default.
- W4387135536 hasConcept C61511704 @default.
- W4387135536 hasConcept C71924100 @default.
- W4387135536 hasConceptScore W4387135536C120665830 @default.
- W4387135536 hasConceptScore W4387135536C121332964 @default.
- W4387135536 hasConceptScore W4387135536C121608353 @default.
- W4387135536 hasConceptScore W4387135536C126322002 @default.
- W4387135536 hasConceptScore W4387135536C126838900 @default.
- W4387135536 hasConceptScore W4387135536C143998085 @default.
- W4387135536 hasConceptScore W4387135536C150173356 @default.
- W4387135536 hasConceptScore W4387135536C167135981 @default.
- W4387135536 hasConceptScore W4387135536C2776694085 @default.
- W4387135536 hasConceptScore W4387135536C2780427987 @default.
- W4387135536 hasConceptScore W4387135536C3019054536 @default.
- W4387135536 hasConceptScore W4387135536C44249647 @default.
- W4387135536 hasConceptScore W4387135536C509974204 @default.
- W4387135536 hasConceptScore W4387135536C61511704 @default.
- W4387135536 hasConceptScore W4387135536C71924100 @default.
- W4387135536 hasLocation W43871355361 @default.
- W4387135536 hasOpenAccess W4387135536 @default.
- W4387135536 hasPrimaryLocation W43871355361 @default.
- W4387135536 hasRelatedWork W2019814960 @default.
- W4387135536 hasRelatedWork W2034286422 @default.
- W4387135536 hasRelatedWork W2376016762 @default.
- W4387135536 hasRelatedWork W2382519083 @default.
- W4387135536 hasRelatedWork W2404042595 @default.
- W4387135536 hasRelatedWork W2805900528 @default.
- W4387135536 hasRelatedWork W2908664330 @default.
- W4387135536 hasRelatedWork W3210326642 @default.
- W4387135536 hasRelatedWork W4291189777 @default.
- W4387135536 hasRelatedWork W4385380379 @default.
- W4387135536 isParatext "false" @default.
- W4387135536 isRetracted "false" @default.
- W4387135536 workType "article" @default.